In the last 12 months, insiders at MoonLake Immunotherapeutics ($MLTX) filed 74 transactions with the SEC: 1 open-market purchases totaling $98,808 and 38 sales totaling $247,978,282. Net insider sentiment: net selling.
MoonLake Immunotherapeutics operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- BVF PARTNERS L P/IL (Director) — 8 transactions totaling $162,965,700
- Chen Bihua (Not found) — 5 transactions totaling $46,868,184
- Reich Kristian (Chief Scientific Officer) — 27 transactions totaling $14,416,391
- Santos da Silva Jorge (Chief Executive Officer) — 14 transactions totaling $13,395,322
- Sturge Simon (Director) — 3 transactions totaling $9,186,120
View all SEC Filings for MoonLake Immunotherapeutics (MLTX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | BVF PARTNERS L P/IL | Director | S | Class A Ordinary Shares, $0.0001 par value | 1932354 | $16.79 | 8,302,735.0000 | 64,037,478 | 18.88% | 3.02% |
| March 31, 2026 | BVF PARTNERS L P/IL | Director | S | Class A Ordinary Shares, $0.0001 par value | 1569116 | $16.79 | 6,599,722.0000 | 64,037,478 | 19.21% | 2.45% |
| March 31, 2026 | BVF PARTNERS L P/IL | Director | S | Class A Ordinary Shares, $0.0001 par value | 248530 | $16.79 | 1,039,238.0000 | 64,037,478 | 19.30% | 0.39% |
| Jan. 7, 2026 | Santos da Silva Jorge | Chief Executive Officer | A | Stock Option (Right to Buy) | 520342 | $0.00 | 520,342.0000 | 64,037,478 | 9999.99% | 0.81% |
| Jan. 7, 2026 | Reich Kristian | Chief Scientific Officer | A | Stock Option (Right to Buy) | 520342 | $0.00 | 520,342.0000 | 64,037,478 | 9999.99% | 0.81% |
| Jan. 7, 2026 | Bodenstedt Matthias | Chief Financial Officer | A | Class A ordinary shares, par value $0.0001 per share | 354296 | $0.00 | 1,276,305.0000 | 64,037,478 | 38.43% | 0.55% |
| Dec. 19, 2025 | Reich Kristian | Chief Scientific Officer | C | Common shares, par value CHF 0.10 per share, of MoonLake AG | 1052 | $0.00 | 0.0000 | 64,037,478 | 100.00% | 0.00% |
| Dec. 19, 2025 | Santos da Silva Jorge | Chief Executive Officer | D | Class C ordinary shares, par value $0.0001 per share | 196316 | $0.00 | 0.0000 | 64,037,478 | 100.00% | 0.31% |
| Dec. 19, 2025 | Bodenstedt Matthias | Chief Financial Officer | C | Class A ordinary shares, par value $0.0001 per share | 294473 | $0.00 | 922,009.0000 | 64,037,478 | 46.93% | 0.46% |
| Dec. 19, 2025 | Bodenstedt Matthias | Chief Financial Officer | D | Class C ordinary shares, par value $0.0001 per share | 294473 | $0.00 | 0.0000 | 64,037,478 | 100.00% | 0.46% |
| Dec. 19, 2025 | Bodenstedt Matthias | Chief Financial Officer | C | Common shares, par value CHF 0.10 per share, of MoonLake AG | 8754 | $0.00 | 0.0000 | 64,037,478 | 100.00% | 0.01% |
| Dec. 19, 2025 | Reich Kristian | Chief Scientific Officer | C | Class A ordinary shares, par value $0.0001 per share | 35389 | $0.00 | 3,009,940.0000 | 64,037,478 | 1.19% | 0.06% |
| Dec. 19, 2025 | Reich Kristian | Chief Scientific Officer | D | Class C ordinary shares, par value $0.0001 per share | 35389 | $0.00 | 0.0000 | 64,037,478 | 100.00% | 0.06% |
| Dec. 19, 2025 | Santos da Silva Jorge | Chief Executive Officer | C | Common shares, par value CHF 0.10 per share, of MoonLake AG | 5836 | $0.00 | 0.0000 | 64,037,478 | 100.00% | 0.01% |
| Dec. 19, 2025 | Santos da Silva Jorge | Chief Executive Officer | C | Class A ordinary shares, par value $0.0001 per share | 196316 | $0.00 | 3,074,893.0000 | 64,037,478 | 6.82% | 0.31% |
| Dec. 9, 2025 | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 70000 | $14.49 | 2,878,577.0000 | 64,037,478 | 2.37% | 0.11% |
| Dec. 8, 2025 | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 130000 | $15.08 | 2,948,577.0000 | 64,037,478 | 4.22% | 0.20% |
| Dec. 9, 2025 | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 72908 | $14.43 | 2,974,551.0000 | 64,037,478 | 2.39% | 0.11% |
| Dec. 8, 2025 | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 130000 | $15.08 | 3,047,459.0000 | 64,037,478 | 4.09% | 0.20% |
| Oct. 8, 2025 | Bodenstedt Matthias | Chief Financial Officer | P | Class A ordinary shares, par value $0.0001 per share | 10870 | $9.09 | 627,536.0000 | 64,037,478 | 1.76% | 0.02% |
| Sept. 29, 2025 | Chen Bihua | Not found | S | Class A Ordinary Shares | 70748 | $9.38 | 8,423,403.0000 | 62,870,237 | 0.83% | 0.11% |
| Sept. 30, 2025 | Chen Bihua | Not found | S | Class A Ordinary Shares | 5827 | $6.96 | 1,994,173.0000 | 62,870,237 | 0.29% | 0.01% |
| Sept. 29, 2025 | Chen Bihua | Not found | S | Class A Ordinary Shares | 2800000 | $6.61 | 2,000,000.0000 | 62,870,237 | 58.33% | 4.45% |
| Sept. 29, 2025 | Chen Bihua | Not found | S | Class A Ordinary Shares | 3390943 | $7.58 | 4,800,000.0000 | 62,870,237 | 41.40% | 5.39% |
| Sept. 29, 2025 | Chen Bihua | Not found | S | Class A Ordinary Shares | 232460 | $8.40 | 8,190,943.0000 | 62,870,237 | 2.76% | 0.37% |
| Sept. 2, 2025 | Reich Kristian | Chief Scientific Officer | D | Class C ordinary shares, par value $0.0001 per share | 48978 | $0.00 | 35,389.0000 | 62,870,237 | 58.05% | 0.08% |
| Jan. 20, 2025 | Reich Kristian | Chief Scientific Officer | C | Common shares, par value CHF 0.10 per share, of MoonLake AG | 1456 | $0.00 | 1,052.0000 | 62,870,237 | 58.05% | 0.00% |
| Sept. 2, 2025 | Reich Kristian | Chief Scientific Officer | C | Class A ordinary shares, par value $0.0001 per share | 48978 | $0.00 | 3,177,459.0000 | 62,870,237 | 1.57% | 0.08% |
| July 3, 2025 | Moukheibir Catherine | Director | M | Option to Buy | 23500 | $0.00 | 21,500.0000 | 62,870,237 | 52.22% | 0.04% |
| July 3, 2025 | Moukheibir Catherine | Director | S | Class A ordinary shares, par value $0.0001 per share | 23500 | $48.79 | 0.0000 | 62,870,237 | 100.00% | 0.04% |
| July 3, 2025 | Moukheibir Catherine | Director | M | Class A ordinary shares, par value $0.0001 per share | 23500 | $0.00 | 23,500.0000 | 62,870,237 | 9999.99% | 0.04% |
| June 5, 2025 | Phillips Andrew John | Director | A | Option to Buy | 6682 | $0.00 | 6,682.0000 | 62,870,237 | 9999.99% | 0.01% |
| June 5, 2025 | Xavier Ramnik | Director | A | Option to Buy | 6682 | $0.00 | 6,682.0000 | 62,870,237 | 9999.99% | 0.01% |
| June 5, 2025 | Loy Spike | Director | A | Option to Buy | 6682 | $0.00 | 6,682.0000 | 62,870,237 | 9999.99% | 0.01% |
| June 5, 2025 | Sturge Simon | Director | A | Option to Buy | 6682 | $0.00 | 6,682.0000 | 62,870,237 | 9999.99% | 0.01% |
| June 5, 2025 | BVF PARTNERS L P/IL | Director | A | Option to Buy | 6682 | $0.00 | 25,667.0000 | 62,870,237 | 35.20% | 0.01% |
| June 5, 2025 | Moukheibir Catherine | Director | A | Option to Buy | 6682 | $0.00 | 6,682.0000 | 62,870,237 | 9999.99% | 0.01% |
| Feb. 27, 2025 | Santos da Silva Jorge | Chief Executive Officer | A | Class A ordinary shares, par value $0.0001 per share | 95763 | $0.00 | 3,078,577.0000 | 62,870,237 | 3.21% | 0.15% |
| Feb. 27, 2025 | Reich Kristian | Chief Scientific Officer | A | Stock Option (Right to Buy) | 139273 | $0.00 | 139,273.0000 | 62,870,237 | 9999.99% | 0.22% |
| Feb. 27, 2025 | Bodenstedt Matthias | Chief Financial Officer | A | Class A ordinary shares, par value $0.0001 per share | 95763 | $0.00 | 616,666.0000 | 62,870,237 | 18.38% | 0.15% |
| Jan. 20, 2025 | Reich Kristian | Chief Scientific Officer | C | Class A ordinary shares, par value $0.0001 per share | 111949 | $0.00 | 3,079,503.0000 | 62,870,237 | 3.77% | 0.18% |
| Jan. 20, 2025 | Reich Kristian | Chief Scientific Officer | D | Class C ordinary shares, par value $0.0001 per share | 111949 | $0.00 | 84,367.0000 | 62,870,237 | 57.02% | 0.18% |
| Jan. 20, 2025 | Reich Kristian | Chief Scientific Officer | C | Common shares, par value CHF 0.10 per share, of MoonLake AG | 3328 | $0.00 | 2,508.0000 | 62,870,237 | 57.03% | 0.01% |
| Oct. 4, 2024 | BVF PARTNERS L P/IL | Director | S | Class A Ordinary Shares, $0.0001 par value | 132549 | $50.00 | 1,287,768.0000 | 62,896,782 | 9.33% | 0.21% |
| Oct. 4, 2024 | Sturge Simon | Director | S | Class A ordinary shares, par value $0.0001 per share | 171000 | $53.72 | 171,980.0000 | 62,896,782 | 49.86% | 0.27% |
| Oct. 4, 2024 | BVF PARTNERS L P/IL | Director | S | Class A Ordinary Shares, $0.0001 par value | 1030589 | $50.00 | 10,235,089.0000 | 62,896,782 | 9.15% | 1.64% |
| Oct. 4, 2024 | BVF PARTNERS L P/IL | Director | S | Class A Ordinary Shares, $0.0001 par value | 836862 | $50.00 | 8,168,838.0000 | 62,896,782 | 9.29% | 1.33% |
| June 6, 2024 | BVF PARTNERS L P/IL | Director | A | Option to Buy | 7688 | $0.00 | 18,985.0000 | 49,122,534 | 68.05% | 0.02% |
| June 6, 2024 | Sturge Simon | Director | A | Option to Buy | 7688 | $0.00 | 7,688.0000 | 49,122,534 | 9999.99% | 0.02% |
| June 6, 2024 | Moukheibir Catherine | Director | A | Option to Buy | 7688 | $0.00 | 7,688.0000 | 49,122,534 | 9999.99% | 0.02% |
| June 6, 2024 | Phillips Andrew John | Director | A | Option to Buy | 7688 | $0.00 | 7,688.0000 | 49,122,534 | 9999.99% | 0.02% |
| June 6, 2024 | Xavier Ramnik | Director | A | Option to Buy | 7688 | $0.00 | 7,688.0000 | 49,122,534 | 9999.99% | 0.02% |
| June 6, 2024 | Loy Spike | Director | A | Option to Buy | 7688 | $0.00 | 7,688.0000 | 49,122,534 | 9999.99% | 0.02% |
| Feb. 27, 2024 | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 29491 | $55.00 | 2,999,464.0000 | 49,122,534 | 0.97% | 0.06% |
| Feb. 28, 2024 | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 28090 | $55.00 | 2,967,554.0000 | 49,122,534 | 0.94% | 0.06% |
| Feb. 28, 2024 | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 31910 | $55.00 | 2,967,554.0000 | 49,122,534 | 1.06% | 0.06% |
| Feb. 27, 2024 | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 29431 | $55.00 | 2,995,644.0000 | 49,122,534 | 0.97% | 0.06% |
| Feb. 29, 2024 | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 4740 | $55.89 | 2,982,814.0000 | 49,122,534 | 0.16% | 0.01% |
| Feb. 28, 2024 | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 56065 | $55.00 | 2,987,554.0000 | 49,122,534 | 1.84% | 0.11% |
| Feb. 27, 2024 | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 62810 | $55.00 | 3,043,619.0000 | 49,122,534 | 2.02% | 0.13% |
| Feb. 21, 2024 | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 1125 | $55.27 | 3,106,429.0000 | 49,122,534 | 0.04% | 0.00% |
| Feb. 21, 2024 | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 569 | $55.30 | 3,086,476.0000 | 49,122,534 | 0.02% | 0.00% |
| Feb. 20, 2024 | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 10000 | $57.45 | 3,086,985.0000 | 49,122,534 | 0.32% | 0.02% |
| Feb. 20, 2024 | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 10000 | $57.43 | 3,087,045.0000 | 49,122,534 | 0.32% | 0.02% |
| Feb. 21, 2024 | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 509 | $55.31 | 3,086,476.0000 | 49,122,534 | 0.02% | 0.00% |
| Feb. 16, 2024 | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 20000 | $60.15 | 3,127,554.0000 | 49,122,534 | 0.64% | 0.04% |
| Feb. 15, 2024 | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 20000 | $60.18 | 3,147,554.0000 | 49,122,534 | 0.63% | 0.04% |
| Feb. 20, 2024 | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 20000 | $57.44 | 3,107,554.0000 | 49,122,534 | 0.64% | 0.04% |
| Feb. 15, 2024 | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 10000 | $60.17 | 3,117,554.0000 | 49,122,534 | 0.32% | 0.02% |
| Feb. 16, 2024 | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 10000 | $60.15 | 3,107,554.0000 | 49,122,534 | 0.32% | 0.02% |
| Feb. 16, 2024 | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 10000 | $60.15 | 3,107,554.0000 | 49,122,534 | 0.32% | 0.02% |
| Feb. 14, 2024 | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 10000 | $62.42 | 3,127,554.0000 | 49,122,534 | 0.32% | 0.02% |
| Feb. 15, 2024 | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 10000 | $60.16 | 3,117,554.0000 | 49,122,534 | 0.32% | 0.02% |
| Feb. 14, 2024 | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 10000 | $62.43 | 3,127,554.0000 | 49,122,534 | 0.32% | 0.02% |